Who Paid My Doc
Acuvue
Device Soft Contact Lenses
General payments
$18,414,839
Research payments
$2,824,042
Through program year 2025, $18,414,839 in general payments and $2,824,042 in research payments were reported against Acuvue (Soft Contact Lenses).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
14 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,370,830 | 8,438 |
| 2025 | Research | $832,654 | 43 |
| 2024 | General | $2,286,631 | 5,735 |
| 2024 | Research | $335,227 | 39 |
| 2023 | General | $3,822,978 | 35,798 |
| 2023 | Research | $651,482 | 42 |
| 2022 | General | $3,980,574 | 37,072 |
| 2022 | Research | $307,960 | 17 |
| 2021 | General | $2,124,668 | 24,166 |
| 2021 | Research | $219,818 | 15 |
| 2020 | General | $1,586,312 | 14,294 |
| 2020 | Research | $111,006 | 8 |
| 2019 | General | $2,242,847 | 28,060 |
| 2019 | Research | $365,894 | 18 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
153,563 general · 182 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.